Norman Payson - 17 Nov 2021 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Jennifer Bealer, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
17 Nov 2021
Transactions value $
-$1,019,008
Form type
4
Filing time
19 Nov 2021, 15:15:29 UTC
Previous filing
12 Nov 2021
Next filing
26 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Sale -$218,939 -3,498 -0.58% $62.59 602,148 17 Nov 2021 See Footnote F1, F2, F3, F4
transaction PGNY Common Stock Sale -$276,342 -4,328 -0.72% $63.85 597,820 17 Nov 2021 See Footnote F1, F3, F4, F5
transaction PGNY Common Stock Sale -$32,492 -504 -0.08% $64.47 597,316 17 Nov 2021 See Footnote F1, F3, F4, F6
transaction PGNY Common Stock Sale -$56,100 -1,000 -0.17% $56.1 596,316 18 Nov 2021 See Footnote F1, F3, F4, F7
transaction PGNY Common Stock Sale -$28,580 -500 -0.08% $57.16 595,816 18 Nov 2021 See Footnote F1, F3, F4, F8
transaction PGNY Common Stock Sale -$58,330 -1,000 -0.17% $58.33 594,816 18 Nov 2021 See Footnote F1, F3, F4, F9
transaction PGNY Common Stock Sale -$203,090 -3,430 -0.58% $59.21 591,386 18 Nov 2021 See Footnote F1, F3, F4, F10
transaction PGNY Common Stock Sale -$139,035 -2,300 -0.39% $60.45 589,086 18 Nov 2021 See Footnote F1, F3, F4, F11
transaction PGNY Common Stock Sale -$6,097 -100 -0.02% $60.97 588,986 18 Nov 2021 See Footnote F1, F4
holding PGNY Common Stock 122,493 17 Nov 2021 See Footnote F12
holding PGNY Common Stock 8,652 17 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.35 to $63.23, inclusive.
F3 The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6) , (7), (8), (9), (10) and (11).
F4 The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.30, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.61, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.725 to $56.70, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.73 to $57.55, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.75 to $58.705, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.82 to $59.76, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.905 to $60.89, inclusive.
F12 The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.